219685-93-5

Basic information

• Product Name: h5G1.1-scFv
• Synonyms: h5G1.1-scFv;Immunoglobulin, anti-(human complement C5 alpha-chain) (human-mouse monoclonal 5G11-sc single chain);Pexelizumab
• CAS NO: 219685-93-5
• Mol File: 219685-93-5.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: h5G1.1-scFv(CAS DataBase Reference)
• NIST Chemistry Reference: h5G1.1-scFv(219685-93-5)
• EPA Substance Registry System: h5G1.1-scFv(219685-93-5)

Safety Data

• Hazardous Substances Data: 219685-93-5(Hazardous Substances Data)

Usage

Description

h5G1.1-scFv is a humanized monoclonal antibody that is engineered to specifically target and neutralize the effects of certain proteins or molecules in the body. It is designed to have high specificity and affinity for its target, making it a valuable tool in various applications.

Uses

Used in Cardiopulmonary Bypass:
h5G1.1-scFv is used as a therapeutic agent for reducing the impact of complement-mediated injuries sustained during cardiopulmonary bypass. It works by binding to specific target molecules, preventing the activation of the complement system and reducing the associated tissue damage and inflammation.
Used in Research and Development:
h5G1.1-scFv can also be used as a research tool for studying the mechanisms of complement-mediated injuries and the role of specific proteins or molecules in these processes. It can be used to generate new insights and develop new therapeutic strategies for the prevention and treatment of complement-mediated injuries.
Used in Drug Development:
h5G1.1-scFv can be used as a starting point for the development of new drugs targeting complement-mediated injuries. By identifying the specific target molecules and their roles in the injury process, researchers can design and develop new drugs that are more effective and have fewer side effects.
Used in Diagnostics:
h5G1.1-scFv can be used as a diagnostic tool for detecting the presence of specific target molecules in patient samples. This can help in the early detection and diagnosis of complement-mediated injuries, allowing for timely intervention and treatment.
Overall, h5G1.1-scFv is a versatile and valuable tool in the field of medicine, with potential applications in therapeutics, research, drug development, and diagnostics. Its high specificity and affinity for its target make it a promising candidate for further investigation and development.